How Did Sovaldi Contribute to Pharma Industry Xmas Carol #2?

On the second day of Christmas my true love gave to me: A brilliant cure for Hepatitis C.

Yes indeed, Gilead has amazed the specialty pharma industry in an unprecedented first year sales record, going on $11 billion dollars for 2014 alone! With their new Rx drug- Sovaldi.


Overpriced at $84,000 dollars or not, Sovaldi has not even penetrated 5% of the possible U.S. market, and that’s only on its first year.
And so, our ’12 Days of Christmas’ Carol continues with this astounding new King of Rx first-year-sales- Sovaldi.


Norton, Tom. How Gilead “Blew Out the Lights” with Sovaldi [Internet]. 2014 November 19. Available from: